Similar Articles |
|
The Motley Fool October 31, 2005 Stephen D. Simpson |
Kinetic Takes a Flesh Wound Although a recent reimbursement decision was unexpected for this wound care specialist, the stock market seems to have overreacted. Investors, take note. |
The Motley Fool January 30, 2006 Stephen D. Simpson |
Healing Growth for Kinetic Concepts Reimbursement and competition are becoming bigger threats, but the wound-care specialist is still a leader in a large market. Investors may want to put this one high up on their watch lists. |
The Motley Fool August 4, 2006 Stephen D. Simpson |
Ruling Slows Down Kinetic Concepts Losing a key patent case will become a severe blow for this med-tech company if it isn't overturned on appeal. Investors, beware. |
The Motley Fool April 25, 2006 Stephen D. Simpson |
Kinetic Energy Although Kinetic Concepts' key patent trial has yet to begin, the stock of this wound-care specialist has been lurching up as investors apparently get a little more comfortable with the risk-reward tradeoff. |
The Motley Fool January 27, 2009 Brian Orelli |
Not All Medical Device Makers Are Hurting While slowdowns in capital spending at hospitals wreaked havoc on other medical-device makers Kinetic Concepts seems to have been able to get through it with only minor bruises. |
The Motley Fool April 22, 2009 Brian Orelli |
You Left Out the Kitchen Sink, KC There was something for nearly everyone in this quarter's earnings release from Kinetic Concepts. The company's three segments ran the gamut of what's possible in this economy. |
BusinessWeek September 12, 2005 Mara Der Hovanesian |
Healing Ahead For Kinetic Concepts Kinetic Concepts, which markets wound-healing and tissue-repair devices, now trades at 55. |
The Motley Fool July 21, 2011 |
Kinetic Concepts Earnings Preview Kinetic Concepts, a global medical technology company, will unveil its latest earnings on Tuesday, July 26. |
The Motley Fool April 8, 2008 Brian Orelli |
Kinetic Concepts Grafts On a New Division Wound-management products company Kinetic Concepts buys tissue-repair product manufacturer LifeCell for a premium. |
The Motley Fool May 27, 2010 Rich Smith |
This Just In: Upgrades and Downgrades Brigantine recommends purchase of Kinetic Concepts in the medical products arena. |
IndustryWeek December 16, 2009 |
IW50 Profile: Kinetic Concepts -- How Kinetic Concepts Stays Healthy Medical products manufacturer has a strategy for thriving during tough economic times. |
The Motley Fool July 27, 2006 Stephen D. Simpson |
Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space. |
The Motley Fool June 14, 2010 Todd Wenning |
One of the Riskiest Investments You Can Make You can make money buying shares of well-run companies; there just needs to be another factor the market is missing, in order for you to buy them at the right price. |
The Motley Fool July 26, 2006 Stephen D. Simpson |
Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow. |
InternetNews April 9, 2009 Stuart J. Johnston |
Microsoft's Patent Tab: $388M Ought to Do It Jury finds that Microsoft infringed a California company's activation software patent to the tune of nearly $400 million. |
The Motley Fool October 31, 2005 Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool January 26, 2006 Stephen D. Simpson |
Little Bits Add Up at Becton Dickinson Nothing flashy here, but consistent performance has delivered exceptional value for this health care and medical technology company. This stock has been nearly a 46-bagger over the past 20 years. |
The Motley Fool April 20, 2006 Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
Bio-IT World June 17, 2004 Cathryn Campbell |
Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more. |
The Motley Fool August 21, 2006 Stephen D. Simpson |
Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence. |
IndustryWeek December 1, 2008 Jill Jusko |
Litigation Nation: By the Numbers Patent infringement claims bedevil manufacturers, survey finds. |
The Motley Fool August 23, 2006 Stephen D. Simpson |
Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution. |
Bio-IT World November 19, 2004 Lentini & Bent |
Intellectual Property: Patents and Genomic Medicine Patents, so critical to encouraging investment in developing new technologies, threaten to become a legal and economic minefield that could prevent effective commercial exploitation of genomics. |
The Motley Fool January 23, 2009 Brian Orelli |
Intuitive Surgical Is Taking Cues From Warren Buffett Even with the paltry projected growth predicted in the short-term, Intuitive Surgical looks like a good long-term investment. |
The Motley Fool February 24, 2004 Rick Aristotle Munarriz |
A Little Kinetic Energy Kinetic goes public in an energetic market, but should you be in a hurry to buy in? |
The Motley Fool January 30, 2006 Stephen D. Simpson |
Respironics in Thin Air Respironics has a great business in the sleep apnea duopoly, but it's still expensive. Investors, take note. |
The Motley Fool May 8, 2006 Stephen D. Simpson |
A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company. |
The Motley Fool May 4, 2006 Stephen D. Simpson |
Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility. |